BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35583364)

  • 1. Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.
    Nogales A; Steel J; Liu WC; Lowen AC; Rodriguez L; Chiem K; Cox A; García-Sastre A; Albrecht RA; Dewhurst S; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0007822. PubMed ID: 35583364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
    Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.
    White CL; Chiem K; Perez DR; Santos J; Cardenas Garcia S; Nogales A; Martínez-Sobrido L
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34208979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
    Pena L; Vincent AL; Ye J; Ciacci-Zanella JR; Angel M; Lorusso A; Gauger PC; Janke BH; Loving CL; Perez DR
    J Virol; 2011 Jan; 85(1):456-69. PubMed ID: 20962084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity.
    Cox A; Schmierer J; D'Angelo J; Smith A; Levenson D; Treanor J; Kim B; Dewhurst S
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33142846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A/WSN/33 viruses.
    Broadbent AJ; Santos CP; Godbout RA; Subbarao K
    J Virol; 2014 Nov; 88(21):12339-47. PubMed ID: 25122786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.
    Zhou B; Meliopoulos VA; Wang W; Lin X; Stucker KM; Halpin RA; Stockwell TB; Schultz-Cherry S; Wentworth DE
    J Virol; 2016 Oct; 90(19):8454-63. PubMed ID: 27440882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral Polymerase.
    Mori K; Ohniwa RL; Takizawa N; Naito T; Saito M
    J Virol; 2021 May; 95(12):. PubMed ID: 33827947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.
    Rodriguez L; Blanco-Lobo P; Reilly EC; Maehigashi T; Nogales A; Smith A; Topham DJ; Dewhurst S; Kim B; Martínez-Sobrido L
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31658679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
    Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
    PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of live-attenuated influenza virus.
    He W; Wang W; Han H; Wang L; Zhang G; Gao B
    PLoS One; 2013; 8(3):e60413. PubMed ID: 23555969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
    Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine.
    Hilimire TA; Nogales A; Chiem K; Ortego J; Martinez-Sobrido L
    Pathogens; 2020 Jan; 9(2):. PubMed ID: 32013198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
    Front Immunol; 2019; 10():756. PubMed ID: 31105689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.
    Loving CL; Vincent AL; Pena L; Perez DR
    Vaccine; 2012 Aug; 30(40):5830-8. PubMed ID: 22835742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.
    Zhou B; Li Y; Speer SD; Subba A; Lin X; Wentworth DE
    Vaccine; 2012 May; 30(24):3691-702. PubMed ID: 22449422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP
    PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.
    Solórzano A; Ye J; Pérez DR
    J Virol; 2010 May; 84(9):4587-96. PubMed ID: 20181702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.